Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor‐infiltrating lymphocytes for the treatment of metastatic cancer
Marnix H. Geukes Foppen, Marco Donia, Inge Marie Svane, et al.
Molecular Oncology (2015) Vol. 9, Iss. 10, pp. 1918-1935
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Advancing therapy for osteosarcoma
Jonathan Gill, Richard Görlick
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 10, pp. 609-624
Closed Access | Times Cited: 554
T cell receptor (TCR) signaling in health and disease
Kinjal Shah, Amr Al‐Haidari, Jianmin Sun, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 324
Tumor organoid–T-cell coculture systems
Chiara Cattaneo, Krijn K. Dijkstra, Lorenzo F. Fanchi, et al.
Nature Protocols (2019) Vol. 15, Iss. 1, pp. 15-39
Open Access | Times Cited: 272
Cervical cancer therapies: Current challenges and future perspectives
Carly A. Burmeister, Saif F. Khan, Georgia Schäfer, et al.
Tumour Virus Research (2022) Vol. 13, pp. 200238-200238
Open Access | Times Cited: 250
Tissue-resident memory T cells at the center of immunity to solid tumors
Derk Amsen, Klaas P. J. M. van Gisbergen, Pleun Hombrink, et al.
Nature Immunology (2018) Vol. 19, Iss. 6, pp. 538-546
Closed Access | Times Cited: 249
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
Giuseppe Badalamenti, Daniele Fanale, Lorena Incorvaia, et al.
Cellular Immunology (2018) Vol. 343, pp. 103753-103753
Closed Access | Times Cited: 200
The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma
Marie‐Françoise Heymann, Frédéric Lézot, Dominique Heymann
Cellular Immunology (2017) Vol. 343, pp. 103711-103711
Open Access | Times Cited: 192
Gene editing and CRISPR in the clinic: current and future perspectives
Matthew P. Hirakawa, Raga Krishnakumar, Jerilyn A. Timlin, et al.
Bioscience Reports (2020) Vol. 40, Iss. 4
Open Access | Times Cited: 167
Cell Therapy: Types, Regulation, and Clinical Benefits
Abed El-Hakim El-Kadiry, Moutih Rafei, Riam Shammaa
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 160
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
Jingjing He, Xinxin Xiong, Han Yang, et al.
Cell Research (2022) Vol. 32, Iss. 6, pp. 530-542
Open Access | Times Cited: 116
Cancer immunotherapy: Challenges and limitations
Sina Taefehshokr, Aram Parhizkar, Shima Hayati, et al.
Pathology - Research and Practice (2021) Vol. 229, pp. 153723-153723
Closed Access | Times Cited: 109
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
Yueshui Zhao, Jian Deng, Shuangfeng Rao, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4160-4160
Open Access | Times Cited: 99
Targeting immune checkpoints in breast cancer: an update of early results
Cinzia Solinas, Andrea Gombos, Sofiya Latifyan, et al.
ESMO Open (2017) Vol. 2, Iss. 5, pp. e000255-e000255
Open Access | Times Cited: 146
Immunotherapies and Combination Strategies for Immuno-Oncology
Cody Barbari, Tyler Fontaine, Priyanka Parajuli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5009-5009
Open Access | Times Cited: 103
Cancer immunotherapy: Strategies for personalization and combinatorial approaches
Vishwanath Sathyanarayanan, Sattva S. Neelapu
Molecular Oncology (2015) Vol. 9, Iss. 10, pp. 2043-2053
Open Access | Times Cited: 97
Antimicrobial Peptides: Potential Application in Liver Cancer
Chunye Zhang, Ming Yang, Aaron C. Ericsson
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 90
Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma
Isabel Poschke, Marta Faryna, Frank Bergmann, et al.
OncoImmunology (2016) Vol. 5, Iss. 12, pp. e1240859-e1240859
Open Access | Times Cited: 88
T Lymphocyte-Captured DNA Network for Localized Immunotherapy
Chi Yao, Chenxu Zhu, Jianpu Tang, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 46, pp. 19330-19340
Closed Access | Times Cited: 75
Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
Fabio Morandi, Mahboubeh Yazdanifar, Claudia Cocco, et al.
Cells (2020) Vol. 9, Iss. 8, pp. 1757-1757
Open Access | Times Cited: 73
Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future
Allison Betof Warner, Pippa Corrie, Omid Hamid
Clinical Cancer Research (2022) Vol. 29, Iss. 10, pp. 1835-1854
Open Access | Times Cited: 51
Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis
Hina Qayoom, Shazia Sofi, Manzoor Ahmad Mir
Immunologic Research (2023) Vol. 71, Iss. 4, pp. 588-599
Closed Access | Times Cited: 40
Combining PARP Inhibition, Radiation, and Immunotherapy: A Possible Strategy to Improve the Treatment of Cancer?
Mathieu Césaire, Juliette Thariat, Serge M. Candéias, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3793-3793
Open Access | Times Cited: 71
MAGE-A antigens as targets for cancer immunotherapy
Erik van Schooten, Alessia Di Maggio, Paul M.P. van Bergen en Henegouwen, et al.
Cancer Treatment Reviews (2018) Vol. 67, pp. 54-62
Open Access | Times Cited: 69
Cells as advanced therapeutics: State-of-the-art, challenges, and opportunities in large scale biomanufacturing of high-quality cells for adoptive immunotherapies
Nate J. Dwarshuis, Kirsten Parratt, Adriana N. Santiago-Miranda, et al.
Advanced Drug Delivery Reviews (2017) Vol. 114, pp. 222-239
Open Access | Times Cited: 62
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy
Christopher B. Driscoll, Matthew Schuelke, Timothy Kottke, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top